Mohammad AskarPublic working copy · medical review pending

Cataract in uveitis · 111

Cataract surgery in uveitis: control the inflammation, then operate

In cataract with uveitis, inflammatory activity, associated damage and surgical anatomy guide management. A prepared, preferably quiet eye and close follow-up improve the conditions for surgery.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Aim for a quiet eye before surgery, usually at least 3 months and longer in selected diseases such as Behçet. Use perioperative steroids, minimise iris and capsular trauma, choose a monofocal hydrophobic acrylic lens in most adults, and follow the eye closely for CME, pressure rise, PCO and phimosis. The evidence does not define one best lens for every uveitic eye.

Terminology and draft status

Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.

01Why a uveitic cataract is a different operation

A uveitic cataract is not simply a denser lens. The eye may have synechiae, a small or fibrotic pupil, weak zonules, a damaged macula or optic nerve, and a disease that can reactivate after surgery. The original calls this a high-risk situation and lists four pillars: patient selection, medical preparation, minimal surgical trauma and long-term vigilance. That framework is sound. 1 4

The central rule is that inflammation controls the surgeon, not the reverse. Operating on an actively inflamed eye, or implanting a lens into poorly controlled inflammation, raises the risk of fibrin, synechiae, cystoid macular oedema, glaucoma and recurrence. The reviewed article advises deferring lens implantation in poorly controlled uveitis and in children under 2 years. 1 4

Plan inflammation control, surgery and follow-up with the uveitis team. Urgent surgery or childhood amblyopia risk may require an individual plan before the usual quiescent interval has been reached. 1

02Before surgery: quiescence, grading and workup

The reviewed article requires the eye to be quiescent for at least 3 months before surgery and well controlled throughout the postoperative period. It notes a longer preoperative interval of at least 6 months in Behçet disease, because postoperative recurrence is related to the frequency of attacks in the preceding 12 months. The 3-month figure is a common target, not a universal legal rule; the disease and the individual eye decide. 1 4

The 2021 retrospective cohort included 149 eyes of 114 patients; 31 eyes (20.8%) recurred within 90 days. Quiescence of at most 30 days was associated with more recurrence (odds ratio 6.11; 95% CI 2.48–15.06; p = 0.0001); at 6 months IOP with recurrence was 16.1 versus 13.0 mmHg (p = 0.0009), and visual change was 0.429 versus 0.318 logMAR (p = 0.292). Selection and confounding limit interpretation: this proves neither equivalent visual change nor adequate safety of 30 days compared with 3 months. 3

SUN defines inactive anterior chamber inflammation as cell grade 0; 0.5+ is not inactive. In contrast, flare of 1+ alone does not establish a new flare even in juvenile idiopathic arthritis (JIA), because chronic blood-aqueous barrier damage can persist; assess cells, trajectory and other findings together. 1 2

Hypotony can suggest ciliary dysfunction and rubeosis can suggest ischaemia; both need causal assessment. Examine macula and optic nerve, use OCT when the view permits, B-scan when the fundus cannot be seen, and fluorescein angiography selectively for suspected vasculitis rather than requiring every test in every eye. 1 4

Avoid a retrobulbar block in a uveitic eye when the sclera may be thinned, for example after posterior scleritis, because of perforation risk. Sub-Tenon, topical or intracameral anaesthesia is preferred. The reviewed article also notes that a peribulbar block may be considered for comfort during iris manipulation. The safe choice depends on the eye, the likely surgical duration and the anaesthetist, and it should be planned rather than defaulted. 1 4

03Steroids, antivirals and immunomodulators around surgery

The original prednisolone acetate preparation about 1 week before surgery is an example of steroid cover. Frequency, duration and additional local or systemic treatment depend on inflammation, infection status and previous steroid response. 1 4

The review describes intracameral dexamethasone 0.4 mg/0.1 mL; that does not validate the original 0.1 mL drawn directly from an IV ampoule at 3.6 or 6 mg/mL. Ocular formulation, sterility, preservatives, route and local regulatory status must be checked before considering such administration; neither routine use in every case nor the original guaranteed 24-hour effect is established. 1 4

Taper topical steroids slowly after surgery to avoid rebound inflammation. The original says an extremely slow taper is essential; the principle is right, but the exact duration is individual. A sudden stop is a recognised trigger for recurrence, and the patient should understand why the drops are being reduced gradually. 1 4

Herpetic uveitis needs a cause-specific antiviral plan. The original acyclovir 400 mg twice daily from 1 week before to at least 1 month after surgery is not a universal HSV/VZV regimen; the review describes different durations, and history, renal function and pathogen guide the choice. 1 4

Coordinate disease-modifying antirheumatic drugs (DMARDs) with the treating team; continuation is often appropriate but is not an unchanged requirement in infection or other contraindications. The original at least 3–4 days of topical non-steroidal anti-inflammatory drugs (NSAIDs) is not a universal CME schedule; assess benefit, corneal risk and intended duration together. 1 4

04The operation: pupils, capsule and minimal trauma

Release relevant synechiae and pupillary membranes gently; hooks, rings or viscodilation may suit the anatomy. Radial membrane or sphincter cuts are reserved for selected situations because bleeding, lasting pupil damage and uncontrolled tearing can occur. 1 4

Plan an adequate rhexis, originally about 5.5–6.0 mm, matched to optic, capsule and zonules. A small opening favours phimosis, but prophylactic radial cuts can extend and are not a universal recommendation. Capsular support devices may be appropriate for significant zonular weakness. 1 4

Trypan blue improves capsular visibility. The original warns that pure dye may be toxic to already weakened zonules and advises dilution. The reviewed article describes capsular dyes as an aid to visualisation but does not establish that dilution prevents zonular toxicity. Use the dye according to its label and the local protocol; do not treat the dilution claim as proven. 1 4

Remove cortical remnants carefully and limit phaco energy and mechanical trauma. Retained material can promote inflammation, but aggressive polishing must not endanger capsule or zonules, and a “soft eye” is not a surgical endpoint. 1 4

If a posterior capsule rupture occurs, the principles from the rupture review apply: keep the infusion, use dispersive OVD, complete an anterior vitrectomy and choose the lens from the residual support. In a uveitic eye with inadequate capsular support, an anterior chamber lens should be avoided; the reviewed article prefers leaving the eye aphakic and planning a scleral-fixated three-piece lens later, once inflammation has settled. 1 4

05Choosing the lens: material, design and the paediatric question

A monofocal hydrophobic acrylic lens is the usual choice, because it has a low rate of cellular deposits and is widely available. The original calls it the gold standard. The comparative evidence is less absolute: a Cochrane review of four randomised trials found fewer posterior synechiae with hydrophobic acrylic than with silicone in the largest trial of 140 eyes at 1 year, but no significant difference in posterior capsule opacification, corneal oedema, CME or mild decentration. A smaller trial of 60 eyes found no clinical difference between hydrophobic and hydrophilic acrylic at 3 months. 1 4

Avoid multifocal lenses in most uveitic eyes because of contrast loss and decentration risk. Avoid silicone lenses because they interact with silicone oil if retinal surgery is needed later and can obstruct the fundal view. Plate-haptic designs are less stable when capsular phimosis develops. The original calls multifocal lenses absolutely contraindicated and silicone a strict no-go; the practical rule is to avoid them in this population unless there is a compelling individual reason. 1 4

In childhood uveitis, inflammation control, amblyopia and follow-up capacity are central. The original caution about primary IOL in JIA below 10 years and the review’s children below 2 years do not establish mandatory aphakia; a specialist team weighs IOL, optical rehabilitation and risks including glaucoma and cyclitic membranes. 1 4

Infectious uveitis needs pathogen-specific treatment and careful steroid decisions. An internally inconsistent implant passage in the review is not adopted as a recommendation for dexamethasone implantation in infection; it establishes neither a confirmed source error nor a general indication. 1 4

06After surgery: pressure, oedema, PCO and phimosis

Raised pressure can result from steroid response, inflammation, synechiae or pupillary block. Assess and treat the cause; prostaglandin analogues are not absolutely contraindicated in every stable uveitic eye. Marked fibrin requires urgent examination including exclusion of infection before targeted intensification; also watch for iris bombé and hypotony. 1 4

Prevent and treat CME. Topical NSAIDs, a slow steroid taper and control of inflammation are the main levers. The reviewed article supports intensive perioperative steroid cover and notes that intracameral or periocular steroid can be as effective as systemic steroids in selected patients. The choice depends on the macula, the systemic risks and the prior steroid response. 1 4

Posterior capsule opacification is the most common late complication and is more frequent in uveitic eyes, especially in younger patients. The reviewed article reports a PCO incidence of 34.2% to 81.7%, with 3.6% to 32.2% requiring YAG capsulotomy. YAG is indicated when vision or the fundus view is reduced. The reviewed article prefers waiting about 6 months after surgery with inflammation controlled, because of retinal tear and detachment risk; the original says at least 3 months after full quiescence. Both are timing targets, not a rule for every eye. 1 4

Capsular phimosis and membranes can distort the optic or obscure vision. Selected radial YAG cuts or surgical membranectomy may be needed, protecting IOL, capsule and zonules; this differs from prophylactic rhexis-edge cuts. Individualise inflammation treatment and recurrence surveillance. 4

07The summary table and the practical take-home

The table condenses the seven original parameters into a standard and a red flag. Read it as a checklist, not a protocol. The red-flag column carries the corrections: 0.5+ cells is low-grade activity rather than zero, flare needs context, the dexamethasone concentration is not standardised by the original, antiviral duration differs between sources, and lens choice is not proven for every eye. 1 2 3 4

The practical sequence remains: control inflammation, weigh surgical need and quiescent interval, plan ocular-suitable steroid cover and minimise iris and capsular trauma. The 2021 cohort shows higher risk with at most 30 days of quiescence but does not establish that 30 days is as safe as the common 3-month target; then monitor pressure, macula and capsule. 1 3 4

The summary table and the practical take-home
ParameterRecommendation or standardRed flag for revision
Quiescence3 months of quiet eye is the common target; longer in Behçet0.5+ cells are not inactive; flare 1+ alone does not establish a JIA flare.
AnaesthesiaSub-Tenon or topical; peribulbar may be considered for comfortRetrobulbar block carries perforation risk in a thin sclera.
Trypan blueUse according to the label and local protocol; dilution is described but not proven to prevent toxicityThe claim that pure dye is toxic to zonules is retained as the original's warning, not as established fact.
Specific medicationDo not use the original 0.1 mL IV ampoule as an intracameral recipe; see formulation checks in the text.Abrupt steroid withdrawal; an ad-hoc concentration should not be copied.
Viral prophylaxisOriginally from 1 week before to at least 1 month after surgery; check cause and individual regimen.No antiviral cover in herpetic uveitis; the exact duration is individual.
IOL choiceMonofocal hydrophobic acrylic in most adultsSilicone lenses interact with oil; multifocal and plate-haptic designs are avoided.
SurgeryIndividualise the original 5.5–6.0 mm rhexis; no routine radial relaxing incisions.Small rhexis and retained cortex increase phimosis and inflammation.
What are the main learning points?

Control the inflammation before surgery, usually with at least 3 months of quiescence and longer in Behçet. Use perioperative steroid cover, minimise iris and capsular trauma, choose a monofocal hydrophobic acrylic lens in most adults, and follow pressure, macula, capsule and inflammation closely. The evidence does not prove one best lens for every uveitic eye.

When is assessment urgent?

Sudden visual loss, severe pain, marked inflammation, a fibrin web, a hard eye, a flat chamber or new field loss after surgery needs immediate ophthalmic assessment. Do not start, stop or change steroids, antivirals or immunomodulators from this educational text.

References and access status

  1. 1
    Immutable original export; cataract surgery in uveitis guide

    Complete export read. Original attribution, recording and transcript were not independently verified.

  2. 2
    Jabs et al. Standardization of uveitis nomenclature for reporting clinical data (SUN). Am J Ophthalmol 2005. PMID 16196117

    Complete NCBI abstract reread 14 November 2026. Tables 1–5 and definitions read 10 November for review 080 and reused here, not freshly read in full on 14 November.

  3. 3
    Timing of quiescence and uveitis recurrences after cataract surgery. PMID 34164783

    Complete NCBI abstract read 14 November 2026. Retrospective cohort, 149 eyes/114 patients; full report unread.

  4. 4
    Chan, Ti and Chee: Decision-making and management of uveitic cataract. Indian J Ophthalmol 2017. PMID 29208813

    Selected full-text XML sections read 14 November 2026: timing, intraoperative steroids, HSV, general considerations, IOL, paediatric surgery, PCO and phimosis. Complete review, figure pixels and underlying primary reports unread.

Original lecture link